News
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near
ARKO Corp. (ARKO) is Attracting Investor Attention: Here is What You Should Know
ARKO Corp. (ARKO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the
Twilio Stock Soars 9% on Q1 Earnings Beat & FY25 Guidance Raise
Twilio Inc. TWLO shares jumped 9.1% in the extended trading session on Thursday after the company reported better-than-expected first-quarter results and raised guidance for full-year 2025.
The
5 Fidelity Mutual Funds to Buy Amid Market Uncertainty
The U.S. market remains volatile due to shifting foreign policies and rising geopolitical tensions. Investors are still concerned about the impact of new reciprocal tariff policies on domestic
How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
The
How to Boost Your Portfolio with Top Computer and Technology Stocks Set to Beat Earnings
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
Recent Price Trend in Golar LNG (GLNG) is Your Friend, Here's Why
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a
Fast-paced Momentum Stock LATAM (LTM) Is Still Trading at a Bargain
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Viavi Beats Q3 Earnings Estimates on Healthy Revenue Growth
Viavi Solutions Inc. VIAV reported solid third-quarter fiscal 2025 results, with both the top and bottom lines surpassing the Zacks Consensus Estimate. The company reported an increase in revenues
GM Trims Outlook, Halts Buyback Amid Tariffs: Sell the Stock Now?
General Motors GM has lowered its 2025 earnings forecast, warning that new U.S. auto tariffs could cost the company $4-$5 billion. The updated guidance, released yesterday, comes two days after the
Interactive Brokers Reports Y/Y Increase in April Client DARTs
Interactive Brokers Group, Inc. IBKR has released the Electronic Brokerage segment’s performance metrics for April 2025. The segment deals with the clearance and settlement of trades for individual
Ingersoll Rand's Q1 Earnings and Revenues Miss Estimates
Ingersoll Rand Inc. IR reported first-quarter 2025 adjusted earnings of 72 cents per share, which missed the Zacks Consensus Estimate of 73 cents. The bottom line decreased 7.7% year over year.Total
FuboTV Inc. (FUBO) Reports Q1 Loss, Tops Revenue Estimates
FuboTV Inc. (FUBO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.11 per share a year ago. These figures are
Will Solid Segmental Sales Boost TransDigm's Q2 Earnings?
TransDigm Group Incorporated TDG is slated to report second-quarter fiscal 2025 results on May 6, before market open.TransDigm delivered a trailing four-quarter average earnings surprise of 6.50%
DuPont's Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
DuPont de Nemours, Inc. DD registered a loss from continuing operations of $548 million or $1.33 per share for first-quarter 2025. In the year-ago quarter, the company recorded a profit of $183
Telephone & Data Systems (TDS) Reports Q1 Loss, Misses Revenue Estimates
Telephone & Data Systems (TDS) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.10 per share a year ago
United States Cellular (USM) Q1 Earnings and Revenues Miss Estimates
United States Cellular (USM) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.20 per share a year ago
Madison Square Garden (MSGS) Reports Q3 Loss, Misses Revenue Estimates
Madison Square Garden (MSGS) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of $1.48. This compares to earnings of $1.57 per share a year ago. These figures
CBOE Global (CBOE) Q1 Earnings and Revenues Beat Estimates
CBOE Global (CBOE) came out with quarterly earnings of $2.50 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.15 per share a year ago. These
Implied Volatility Surging for Keros Therapeutics Stock Options
Investors in Keros Therapeutics, Inc. KROS need to pay close attention to the stock based on moves in the options market lately. That is because the May 16, 2025 $70.00 Call had some of the highest


